Hemangioendothelioma (overview)

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 06.08.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Mallory, 1908; the historical development of the term is decidedly confusing, with different histological (benign as well as malignant) clinical pictures being subsumed under this term from decade to decade.

DefinitionThis section has been translated automatically.

Today, the term "hemangioendothelioma" refers to a heterogeneous group of low-malignant (borderline) tumors whose dignity is classified between angiomas and angiosarcomas. They grow locally destructive, but metastasize extremely rarely, and then only to the regional lymph nodes. Hemangioendotheliomas include:

HistologyThis section has been translated automatically.

Cytogenetically, hemangioendotheliomas have characteristic translocation-related fusion genes that can be used diagnostically (FISH analysis).

LiteratureThis section has been translated automatically.

  1. Mallory EB (1908) The results of the application of special histological methods to the study of tumors. J Exp Med 10: 575-593

Authors

Last updated on: 06.08.2021